Market Closed -
OTC Markets
10:19:45 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
7.83
USD
|
+11.06%
|
|
-0.89%
|
+552.50%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
61.55
|
27.03
|
23.55
|
2.423
|
21.95
|
-
|
Enterprise Value (EV)
1 |
61.55
|
27.03
|
23.55
|
2.423
|
21.95
|
21.95
|
P/E ratio
|
-7.5
x
|
-2.39
x
|
-2.69
x
|
-0.26
x
|
-2.84
x
|
-3.56
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
87.6
x
|
40.3
x
|
14.6
x
|
EV / Revenue
|
-
|
-
|
-
|
87.6
x
|
40.3
x
|
14.6
x
|
EV / EBITDA
|
-
|
-2.99
x
|
-2.7
x
|
-0.33
x
|
-2.62
x
|
-2.85
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
855
|
1,570
|
1,570
|
2,019
|
2,803
|
-
|
Reference price
2 |
72.00
|
17.22
|
15.00
|
1.200
|
7.830
|
7.830
|
Announcement Date
|
25/02/21
|
22/04/22
|
14/03/23
|
15/03/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
-
|
-
|
0.0276
|
0.545
|
1.508
|
EBITDA
1 |
-
|
-9.053
|
-8.732
|
-7.263
|
-8.372
|
-7.714
|
EBIT
1 |
-
|
-9.053
|
-8.732
|
-7.263
|
-8.46
|
-8.369
|
Operating Margin
|
-
|
-
|
-
|
-26,267.67%
|
-1,552.29%
|
-554.97%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-9.106
|
-
|
-8.745
|
-7.777
|
-8.472
|
-8.381
|
Net margin
|
-
|
-
|
-
|
-28,127.23%
|
-1,554.5%
|
-555.77%
|
EPS
2 |
-9.600
|
-7.200
|
-5.580
|
-4.600
|
-2.760
|
-2.200
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/21
|
22/04/22
|
14/03/23
|
15/03/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
0.00405
|
0.0118
|
0.0118
|
0.02
|
0.075
|
0.15
|
0.3
|
EBITDA
1 |
-3.164
|
-2.027
|
-2.068
|
-2
|
-2.638
|
-1.949
|
-1.801
|
-1.549
|
-1.897
|
-2.206
|
-2.08
|
-2.039
|
-2.047
|
EBIT
1 |
-3.164
|
-2.027
|
-2.068
|
-2
|
-2.638
|
-1.97
|
-1.824
|
-1.572
|
-1.897
|
-2.228
|
-2.102
|
-2.061
|
-2.069
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-45,033.83%
|
-13,325.34%
|
-16,072.8%
|
-11,140%
|
-2,802.67%
|
-1,374%
|
-689.67%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
-2.028
|
-2.072
|
-2.004
|
-2.641
|
-1.973
|
-2.071
|
-1.825
|
-1.909
|
-2.231
|
-2.105
|
-2.064
|
-2.072
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-51,125.19%
|
-15,465.42%
|
-16,174.15%
|
-11,155%
|
-2,806.67%
|
-1,376%
|
-690.67%
|
EPS
2 |
-2.040
|
-1.320
|
-1.320
|
-1.260
|
-1.680
|
-1.260
|
-1.320
|
-1.050
|
-0.9600
|
-0.8000
|
-0.7000
|
-0.6500
|
-0.6100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/04/22
|
13/05/22
|
04/08/22
|
14/11/22
|
14/03/23
|
10/05/23
|
14/08/23
|
13/11/23
|
15/03/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/21
|
22/04/22
|
14/03/23
|
15/03/24
|
-
|
-
|
Last Close Price
7.83
USD Average target price
12
USD Spread / Average Target +53.26% Consensus |
1st Jan change
|
Capi.
|
---|
| +552.50% | 21.95M | | +16.80% | 8.43B | | +15.02% | 6.82B | | -4.77% | 3.77B | | -6.75% | 3.74B | | +4.41% | 1.44B | | -30.34% | 1.06B | | +20.28% | 1.04B | | -12.85% | 890M | | -15.63% | 812M |
Special Foods & Wellbeing Products
|